PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2117033
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2117033
Steam-In-Place System Market size was valued at US$ 2,051.3 Million in 2025, expanding at a CAGR of 10.3% from 2026 to 2033.
Steam-in-place (SIP) sterilizers are devices designed to sterilize processing equipment without disassembly, through a controlled injection of clean steam into the system, past equipment such as vessels, piping, filters, transfer lines, and fillers. The steam generation and distribution, valves, temperature and pressure sensors, controls, heat exchangers, automation, and validation technologies used for the system are key components in this market. The end-users are primarily pharmaceutical and biotechnology companies.
Food, dairy, and beverage product manufacturers also apply SIP technology in their production processes when there is a need to ensure high levels of hygiene and the ability to quickly sterilize equipment. According to the FDA Drug Establishment Current Registration for 2025, there are more than 4,400 pharmaceutical companies worldwide, including firms in the United States, China, Germany, Japan, India, and many other countries. Therefore, SIP sterilizers can be regarded as part of the overall equipment necessary for any pharmaceutical production process, and they are no longer just an option for ensuring quality and sterilization.
Steam-In-Place System Market- Market Dynamics
Stricter Contamination Control Is Elevating Automated Sterilization Requirements
Modern SIPs should allow for precise control, recording, replication, and validation of each step to guarantee total process consistency. Therefore, automation plays a significant role in modern SIPs, which is used to maintain optimal pressure, temperature, and exposure regimes and record all the necessary data with the help of programmable logic controllers, sensors, valves, recipe management systems, and central information storage. In 2025, the European Medicines Agency issued updated guidelines, which confirm the industry's interest in implementing contamination control strategies based on risk assessment during the manufacturing process of sterile medicinal products. This means that SIP suppliers should be prepared to meet the rising demand, considering the tendency to implement automated solutions that ensure the thermal validation of the sterilization cycle and digital documentation of the process.
The Global Steam-In-Place System Market is segmented on the basis of Type, Application, Component, End User, and Region.
By type, automated SIP systems are being preferred to a greater extent due to sterile pharmaceutical and biopharmaceutical facilities are witnessing an emphasis on standardized cycles, reduced human intervention, electronic record-keeping, and simple revalidation. Such systems offer the ability to automate the process of steam inletting, attainment of desired temperatures, exposure time, pressure maintenance, removal of condensates, and cycle ending, which can contribute to more standardized operations for multiple batches. Manual systems are being used in smaller-scale pilot plant facilities and less-intensive processes wherein a lesser degree of automation is required. The International Society for Pharmaceutical Engineering is witnessing an emphasis on digitization and automation driven pharmaceutical production in 2025, with automated SIP systems being prioritized by manufacturers for their ability to offer connected control and contribute to standardization and compliance for manufacturers.
By component, SIP systems consist of multiple components based on the performance needs of the sterilization cycle, clean-steam production, and the need for additional process control and monitoring. Control systems are utilized to manage cycle parameters and record-keeping for validation purposes, with sanitary valves being used for isolating and regulating the flow of steam. Other components include filters, heat exchangers, and sensors, which offer the ability to monitor and manage the process temperatures and pressures for optimal performance. The rising digitalization trends are also encouraging the need for instrumentation that can offer enhanced data transfer to supervisory systems. The International Society for Pharmaceutical Engineering has continued to drive the push toward automated pharmaceutical production in 2025, which makes component performance and its role in SIP systems even more pertinent than before.
Steam-In-Place System Market- Geographical Insights
North America is expected to witness high demand for SIPs on account of the region's well-established pharmaceutical, biotech, and sterile-processing sectors, as well as the high-quality standards prevalent in the region. U.S.-based manufacturers are witnessing a growing need for automated systems that can monitor and record details of each cycle while facilitating robust contamination control processes. North America also offers a deep supply chain of sanitary valves, process control systems, filtration equipment, and bioprocess machinery. Moreover, the U.S. FDA continued to register drug manufacturing companies through its digital portal in 2025, an indication of the large number of manufacturing facilities present within the region. Thus, North America's high level of bioprocessing activity, combined with its extensive and sophisticated engineering networks, is expected to drive demand for advanced SIPs in the region.
Europe is anticipated to be one of the leading regions for SIPs owing to the large number of pharmaceutical, biotechnology, food-processing, and dairy manufacturing facilities present within the region and their high level of automation and quality control. European manufacturers are increasingly prioritizing the use of SIPs that not only offer superior process validation but also incorporate energy-saving measures and advanced features such as automation and data recording. The region also possesses a wide array of engineering firms that design and manufacture sanitary valves, heat exchangers, filtration equipment, and process control systems for use in SIPs. In 2025, the European Medicines Agency continued to impose stringent guidelines pertaining to the manufacture of sterile pharmaceuticals and medical products. Thus, Europe has a high demand for SIPs that incorporate advanced levels of automation and validation.
Competition in the Steam-In-Place system market is focused on the combination of features and integration rather than individual components. Companies compete based on proven sterilization capabilities, sanitary design, degree of automation, control schemes, thermal performance, supply chain support, and bioprocessing platforms. Proven competencies in delivering valves, heat exchangers, sensors, controls, and complete assemblies give suppliers a competitive advantage in a market that favors integrated turnkey solutions for integrated pharmaceutical production sites. Another important factor driving competition is the need for global customer support, as SIP systems require commissioning, validation, maintenance, and technical service across their entire lifecycle. As of 2025, Alfa Laval already operates in over 100 countries, highlighting the importance of this factor to major players in the process equipment market. Therefore, the key areas of competition for Steam-In-Place systems are automated solutions, control schemes, thermal performance, and overall validation support rather than individual components.
In March 2025, Alfa Laval expanded its hygienic process offerings to include more solutions that can be applied in the pharmaceutical and food processing fields, such as those related to automated fluid handling. The company's emphasis on integrated hygienic components supports the combination of process automation, steam management, and contamination control.
In September 2025, GEA Group continued to develop pharmaceutical processing technologies that employed automation and advanced process control and contributed to meeting contamination management needs. The company's offerings are geared toward the growing need to employ digital technologies in sterile and hygienic manufacturing.